AstraZeneca’s AZD0901 is in Phase 3 testing in advanced gastric and GEJ cancers. Elevation Oncology’s ADC, EO-3021, is in early clinical development for advanced solid tumors, including GI ...
The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback